BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25983322)

  • 1. TGF-β induced miR-132 enhances the activation of TGF-β signaling through inhibiting SMAD7 expression in glioma cells.
    Wang ZH; Zhang QS; Duan YL; Zhang JL; Li GF; Zheng DL
    Biochem Biophys Res Commun; 2015 Jul; 463(3):187-92. PubMed ID: 25983322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β1 regulating miR-205/miR-195 expression affects the TGF-β signal pathway by respectively targeting SMAD2/SMAD7.
    Duan Y; Chen Q
    Oncol Rep; 2016 Oct; 36(4):1837-44. PubMed ID: 27574009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway.
    Zhu Z; Xu Y; Zhao J; Liu Q; Feng W; Fan J; Wang P
    Br J Cancer; 2015 Apr; 112(8):1367-75. PubMed ID: 25867271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-181b-induced SMAD7 downregulation controls granulosa cell apoptosis through TGF-β signaling by interacting with the TGFBR1 promoter.
    Yao W; Pan Z; Du X; Zhang J; Li Q
    J Cell Physiol; 2018 Sep; 233(9):6807-6821. PubMed ID: 29319157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus regulates apoptosis and tumorigenesis through the microRNA-15a-Smad7-transforming growth factor beta pathway.
    Liu N; Jiao T; Huang Y; Liu W; Li Z; Ye X
    J Virol; 2015 Mar; 89(5):2739-49. PubMed ID: 25540364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
    Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
    Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased miR-187 induces retinal ganglion cell apoptosis through upregulating SMAD7 in glaucoma.
    Zhang QL; Wang W; Li J; Tian SY; Zhang TZ
    Biomed Pharmacother; 2015 Oct; 75():19-25. PubMed ID: 26463627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-21 induces breast cancer cell invasion and migration by suppressing smad7 via EGF and TGF-β pathways.
    Han M; Wang F; Gu Y; Pei X; Guo G; Yu C; Li L; Zhu M; Xiong Y; Wang Y
    Oncol Rep; 2016 Jan; 35(1):73-80. PubMed ID: 26531758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NR2F2 inhibits Smad7 expression and promotes TGF-β-dependent epithelial-mesenchymal transition of CRC via transactivation of miR-21.
    Wang H; Nie L; Wu L; Liu Q; Guo X
    Biochem Biophys Res Commun; 2017 Mar; 485(1):181-188. PubMed ID: 28192117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-193b promotes cell proliferation by targeting Smad3 in human glioma.
    Zhong Q; Wang T; Lu P; Zhang R; Zou J; Yuan S
    J Neurosci Res; 2014 May; 92(5):619-26. PubMed ID: 24496888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H; Ooi LL; Hui KM
    Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-215, an activator of the CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human glioma.
    Tong YQ; Liu B; Zheng HY; Gu J; Liu H; Li F; Tan BH; Hartman M; Song C; Li Y
    Oncotarget; 2015 Sep; 6(28):25024-33. PubMed ID: 26317904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-21 negatively regulates Treg cells through a TGF-β1/Smad-independent pathway in patients with coronary heart disease.
    Li S; Fan Q; He S; Tang T; Liao Y; Xie J
    Cell Physiol Biochem; 2015; 37(3):866-78. PubMed ID: 26383248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis.
    Halder SK; Beauchamp RD; Datta PK
    Exp Cell Res; 2005 Jul; 307(1):231-46. PubMed ID: 15922743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.
    Smith AL; Iwanaga R; Drasin DJ; Micalizzi DS; Vartuli RL; Tan AC; Ford HL
    Oncogene; 2012 Dec; 31(50):5162-71. PubMed ID: 22286770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor (TGF)-β-induced microRNA-216a promotes acute pancreatitis via Akt and TGF-β pathway in mice.
    Zhang J; Ning X; Cui W; Bi M; Zhang D; Zhang J
    Dig Dis Sci; 2015 Jan; 60(1):127-35. PubMed ID: 25501921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma.
    Sun H; Peng Z; Tang H; Xie D; Jia Z; Zhong L; Zhao S; Ma Z; Gao Y; Zeng L; Luo R; Xie K
    Oncogene; 2017 May; 36(21):2957-2968. PubMed ID: 28192402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer.
    Kleeff J; Ishiwata T; Maruyama H; Friess H; Truong P; Büchler MW; Falb D; Korc M
    Oncogene; 1999 Sep; 18(39):5363-72. PubMed ID: 10498890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-27b Suppresses Endothelial Cell Proliferation and Migration by Targeting Smad7 in Kawasaki Disease.
    Rong X; Ge D; Shen D; Chen X; Wang X; Zhang L; Jia C; Zeng J; He Y; Qiu H; Su X; Chu M
    Cell Physiol Biochem; 2018; 48(4):1804-1814. PubMed ID: 30078021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-497 Modulates Breast Cancer Cell Proliferation, Invasion, and Survival by Targeting SMAD7.
    Liu J; Zhou Y; Shi Z; Hu Y; Meng T; Zhang X; Zhang S; Zhang J
    DNA Cell Biol; 2016 Sep; 35(9):521-9. PubMed ID: 27303812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.